level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 100 /hr
Hire Dr. Layne R.
United States
USD 100 /hr

Expert science communicator eager to dive in to any disease state

Profile Summary
Subject Matter Expertise
Services
Writing Technical Writing
Research Scientific and Technical Research, Systematic Literature Review
Consulting Scientific and Technical Consulting
Data & AI Data Cleaning
Work Experience

Director of Patient Engagement

Friedreich's Ataxia Research Alliance

June 2022 - Present

Postdoctoral Research Fellow

Children's Hospital of Philadelphia

June 2021 - June 2022

PhD student

The University of Oklahoma Health Sciences Center

June 2015 - May 2021

Education

PhD (Neuroscience)

University of Oklahoma Health Sciences Center

January 2015 - May 2021

BS biochemistry (Chemistry and biochemistry)

The University of Oklahoma

August 2010 - May 2015

Certifications
  • PhD neuroscience

    university of Oklahoma

    May 2021 - Present

Publications
JOURNAL ARTICLE
Megan Shen, Rodden LN, McIntyre K, Arias A, Profeta V, Schadt K, david lynch (2022). SARS-CoV-2 in patients with Friedreich ataxia . Journal of neurology.
Rodden LN, Rummey C, Dong YN, Lagedrost S, Regner S, Brocht A, Bushara K, Delatycki MB, Gomez CM, Mathews K, et al. (2022). A non-synonymous single nucleotide polymorphism in <i>SIRT6</i> predicts neurological severity in Friedreich ataxia . Frontiers in molecular biosciences.
Yi Na Dong, Mesaros C, Xu P, Mercado-Ay&#243;n E, Halawani S, Ngaba LV, Warren N, Sleiman P, Rodden LN, Schadt KA, et al. (2022). Frataxin controls ketone body metabolism through regulation of OXCT1 . PNAS nexus.
Keita M, McIntyre K, Rodden LN, Schadt K, david lynch (2022). Friedreich ataxia: clinical features and new developments . Neurodegenerative disease management.
Mercado-Ay&#243;n E, Warren N, Halawani S, Rodden LN, Ngaba L, Dong YN, Chang JC, Fonck C, Mavilio F, Lynch DR, et al. (2022). Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia . Frontiers in neuroscience.
Rodden LN, Kaitlyn M Gilliam, Lam C, Rojsajjakul T, Mesaros C, Dionisi C, Pook M, Pandolfo M, Lynch DR, Blair IA, et al. (2022). DNA methylation in Friedreich ataxia silences expression of frataxin isoform E . Scientific reports.
Rodden LN, Lynch DR (2021). Designing phase II clinical trials in Friedreich ataxia . Expert opinion on emerging drugs.
Rodden LN, Kaitlyn M Gilliam, Lam C, Lynch DR, Bidichandani SI (2021). Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation . Frontiers in neuroscience.